Enterprise Value
1.293B
Cash
329M
Avg Qtr Burn
-24.68M
Short % of Float
27.26%
Insider Ownership
30.48%
Institutional Own.
28.78%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Rilparencel (REACT® Details Chronic kidney disease, Type 2 diabetes | Phase 3 Initiation | |
Rilparencel (REACT® Details Chronic kidney disease, Type 2 diabetes | Phase 3 Initiation | |
Rilparencel (REACT®) Details Chronic kidney disease, Type 2 diabetes | Phase 2 Data readout | |
Rilparencel (REACT® Details Chronic kidney disease, Diabetes | Phase 2 Update |